Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.60748 | 25 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.59324 | 26 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.61166 | 27 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.5584 | 26 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.55033 | 26 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.77228 | 31 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.59072 | 24 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.55885 | 25 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.54919 | 25 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.57725 | 25 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.58004 | 26 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.57269 | 26 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.58134 | 25 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.58447 | 26 |